In people with celiac disease, a bacterial enzyme called microbial transglutaminase might glue together the tiny seals between gut cells, making the gut leakier and letting more of the harmful wheat protein (gliadin) slip through, which could make symptoms worse.
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
probability
Can suggest probability/likelihood
Assessment Explanation
The claim uses 'may' and 'potentially', which correctly reflect the speculative nature of the proposed mechanism. While in vitro and animal studies have shown that microbial transglutaminase can modify tight junction proteins and increase permeability, direct evidence in human celiac patients is limited. The mechanism is biologically plausible based on known enzymatic activity and celiac pathophysiology, but human data confirming translocation of gliadin via this pathway is still emerging. The use of probabilistic language is scientifically appropriate.
Context Details
Domain
medicine
Population
human
Subject
Microbial transglutaminase
Action
may enhance
Target
intestinal permeability in individuals with celiac disease by cross-linking tight junction proteins such as claudins and occludins, potentially facilitating increased gliadin translocation
Intervention Details
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Evidence from Studies
Supporting (1)
This study says that a food additive called microbial transglutaminase can make the gut lining leakier in people with celiac disease, letting harmful wheat proteins slip through more easily—which is exactly what the claim says.